Related Experiment Videos
Congo red analogues as potential anti-prion agents.
Stefania Villa1, Giorgio Cignarella, Daniela Barlocco
1Istituto di Chimica Farmaceutica e Tossicologica, Università degli Studi di Milano, Viale Abruzzi 42, I-20131 Milan, Italy. stefania.villa@unimi.it
Farmaco (Societa Chimica Italiana : 1989)
|September 19, 2003
Summary
New compounds structurally related to Congo red show potential in targeting Transmissible Spongiform Encephalopathies (TSE). These molecules interact with and stabilize the disease-associated prion protein (PrP(res)), a key factor in TSE pathogenesis.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Transmissible Spongiform Encephalopathies (TSEs) are fatal neurodegenerative diseases.
- TSE pathogenesis involves the conversion of normal prion protein (PrP(sen)) to a misfolded, protease-resistant form (PrP(res)).
- PrP(res) accumulation in the brain is a hallmark of TSEs and a therapeutic target.
Purpose of the Study:
- To design and synthesize molecules structurally related to Congo red (CR).
- To evaluate the in vitro interaction of these novel compounds with PrP(res).
- To assess their potential as therapeutic agents for TSEs.
Main Methods:
- Synthesis of CR-analogues (compounds 1a-f, 2f,g).
- In vitro testing for interaction with 263K PrP(res).
- Evaluation of PrP(res) aggregate stabilization and potential reversion to PrP(sen).
Main Results:
- Six synthesized compounds demonstrated interaction with PrP(res) molecules.
- These compounds, similar to CR, over-stabilized PrP(res) aggregates.
- None of the tested compounds induced the reversion of PrP(res) to the normal PrP(sen) form.
Conclusions:
- Structurally CR-related compounds can interact with and stabilize PrP(res) aggregates.
- These findings support the exploration of CR analogues for TSE therapeutic strategies.
- Further research is needed to achieve PrP(res) reversion to PrP(sen).